Document Detail

Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism.
MedLine Citation:
PMID:  8252160     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: In a prospective study we searched for von Willebrand's syndrome during hypothyroidism and investigated the effects of treatment with thyroid hormones on plasma concentrations or activities of the factors involved in von Willebrand's disease in addition to tissue plasminogen activator and plasminogen activator inhibitor 1. METHODS: Eleven patients with hypothyroidism were tested. Factor VIII coagulant activity (VIIIc), von Willebrand factor (vWf:Ag), von Willebrand factor activity (vWf:RCo), tissue plasminogen activator antigen (tPA) and plasminogen activator inhibitor activity (PAI) was monitored before and after correction of hypothyroidism by hormone supplementation. RESULTS: Five patients had laboratory evidence of type I von Willebrand's disease. The other six patients had concentrations or activities of the factors involved in von Willebrand's disease within the normal range. In all cases except one, during thyroxin treatment, von Willebrand factors returned to normal if initially low, or increased clearly if initially normal. With the correction of hypothyroidism, an increase of tPA was noted in the eleven patients, associated with a significant increase of PAI. CONCLUSION: Laboratory evidence of von Willebrand's disease is common during hypothyroidism. Study of plasminogen activator and its inhibitor suggest a decrease of von Willebrand factor synthesis during hypothyroidism.
H Levesque; J Y Borg; N Cailleux; M Vasse; S Daliphard; A Gancel; M Monconduit; H Courtois
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The European journal of medicine     Volume:  2     ISSN:  1165-0478     ISO Abbreviation:  Eur J Med     Publication Date:  1993 May 
Date Detail:
Created Date:  1994-01-11     Completed Date:  1994-01-11     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  9209793     Medline TA:  Eur J Med     Country:  FRANCE    
Other Details:
Languages:  eng     Pagination:  287-8     Citation Subset:  IM    
Service de Médecine Interne, Centre Hospitalier Universitaire de Rouen-Boisguillaume, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Factor VIII / analysis
Hypothyroidism / blood,  complications*,  therapy
Plasminogen Activator Inhibitor 1 / blood*
Plasminogen Activators / blood*
Prospective Studies
von Willebrand Diseases / blood,  etiology*
von Willebrand Factor / analysis
Reg. No./Substance:
0/Plasminogen Activator Inhibitor 1; 0/von Willebrand Factor; 9001-27-8/Factor VIII; EC 3.4.21.-/Plasminogen Activators

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Predictive value of synovial fluid analysis in rheumatoid arthritis. A 7.5-year follow-up study.
Next Document:  Ethical aspects of the doctor-patient relationship.